Microbot Medical Inc (MBOT)
1.04
-0.01
(-0.95%)
USD |
NASDAQ |
Jun 25, 16:00
1.00
-0.04
(-3.85%)
After-Hours: 06:24
Microbot Medical Cash from Financing (Quarterly): 2.397M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.397M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.161M |
| June 30, 2023 | 6.719M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 4.324M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -3.375M |
| December 31, 2019 | 27.21M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 9.562M |
| December 31, 2018 | -0.018M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.397M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 9.54M |
| March 31, 2017 | 3.082M |
| December 31, 2016 | 2.179M |
| September 30, 2016 | 0.154M |
| June 30, 2016 | 0.75M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -20.39M |
| September 30, 2015 | -1.045M |
| June 30, 2015 | 23.68M |
| March 31, 2015 | -1.830M |
| December 31, 2014 | -0.9953M |
| September 30, 2014 | 21.29M |
| June 30, 2014 | -0.7171M |
| March 31, 2014 | 2.616M |
| December 31, 2013 | 16.77M |
| September 30, 2013 | 4.911M |
| June 30, 2013 | 13.01M |
| March 31, 2013 | 1.716M |
| December 31, 2012 | 5.606M |
| September 30, 2012 | 17.08M |
| June 30, 2012 | 2.403M |
| March 31, 2012 | 0.6509M |
| December 31, 2011 | 9.277M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.375M
Minimum
Mar 2020
27.21M
Maximum
Dec 2019
2.474M
Average
--
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 166.33M |
| Retractable Technologies Inc | -0.1313M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.42M |
| Cash from Investing (Quarterly) | -1.284M |
| Free Cash Flow | -7.797M |
| Free Cash Flow Per Share (Quarterly) | -0.1732 |
| Free Cash Flow Yield | -64.08% |